Filed: 2/17/2026ACC: 0001826434-26-000002
📋 What this filing means
TRI LOCUM PARTNERS LP filed this quarterly 13F‑HR report disclosing 15 equity positions with a total reported market value of $770.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
15
Positions
$770.12M
Total AUM (reported)
6.40M
Total Shares
Allocation by class
COM$596.33M77.4%
SPONSORED ADR$88.18M11.4%
SPONSORED ADS$44.81M5.8%
CL A$40.80M5.3%
Portfolio Concentration
Top 3$272.24M35.3%
4–10$344.85M44.8%
11–25$153.04M19.9%
Top 3 weight
35.3%
Top 10 weight
80.1%
Voting Authority Distribution
Total shares with voting rights: 6.40M
Sole
Full voting authority
6.40M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole15
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings15
Rows:
JOHNSON & JOHNSON
SOLEShares603.14K
TypeSH
Market value$124.82M
16.21%
Sole
603.14K
Shared
0.00
None
0.00
DANAHER CORPORATION
SOLEShares346.88K
TypeSH
Market value$79.41M
10.31%
Sole
346.88K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares63.28K
TypeSH
Market value$68.01M
8.83%
Sole
63.28K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares120.92K
TypeSH
Market value$58.92M
7.65%
Sole
120.92K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares265.01K
TypeSH
Market value$56.51M
7.34%
Sole
265.01K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares86.02K
TypeSH
Market value$50.09M
6.50%
Sole
86.02K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares520.51K
TypeSH
Market value$49.63M
6.44%
Sole
520.51K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.44M
TypeSH
Market value$44.81M
5.82%
Sole
1.44M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares557.17K
TypeSH
Market value$44.08M
5.72%
Sole
557.17K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares805.69K
TypeSH
Market value$40.80M
5.30%
Sole
805.69K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares201.63K
TypeSH
Market value$36.83M
4.78%
Sole
201.63K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares37.65K
TypeSH
Market value$31.66M
4.11%
Sole
37.65K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares307.37K
TypeSH
Market value$30.92M
4.01%
Sole
307.37K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares421.60K
TypeSH
Market value$27.98M
3.63%
Sole
421.60K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares622.40K
TypeSH
Market value$25.65M
3.33%
Sole
622.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSONSOLE | COM | 603.14K | SH | $124.82M 16.21% | 603.14K | 0.00 | 0.00 |
DANAHER CORPORATIONSOLE | COM | 346.88K | SH | $79.41M 10.31% | 346.88K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 63.28K | SH | $68.01M 8.83% | 63.28K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 120.92K | SH | $58.92M 7.65% | 120.92K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 265.01K | SH | $56.51M 7.34% | 265.01K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 86.02K | SH | $50.09M 6.50% | 86.02K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 520.51K | SH | $49.63M 6.44% | 520.51K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.44M | SH | $44.81M 5.82% | 1.44M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 557.17K | SH | $44.08M 5.72% | 557.17K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 805.69K | SH | $40.80M 5.30% | 805.69K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 201.63K | SH | $36.83M 4.78% | 201.63K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 37.65K | SH | $31.66M 4.11% | 37.65K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 307.37K | SH | $30.92M 4.01% | 307.37K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 421.60K | SH | $27.98M 3.63% | 421.60K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 622.40K | SH | $25.65M 3.33% | 622.40K | 0.00 | 0.00 |